Biotech Values

[swampboots]

Seriously speaking, has there ever been a cancer targeted drug
which does not in almost 100% of the cases need expected reformulation?
I think it is a wink wink oxymoron to assume otherwise, yet the vocabulary of caution demands each trial has a goal of perfection, as it should be of course.